According to a new report by Polaris Market Research, the global mRNA vaccines and therapeutics market was valued at USD 54.32 billion in 2024 and is projected to reach USD 253.83 billion by 2034, expanding at a CAGR of 16.7% over the forecast period. Growth is underpinned by rising chronic disease burden, expanding cancer immunotherapy pipelines, and accelerating regulatory...